Canada Pension Plan Investment Board’s holdings in Chemours were worth $239,000 as of its most recent SEC filing.

Source: https://www.etfdailynews.com/2023/03/03/canada-pension-plan-investment-board-acquires-7400-shares-of-the-chemours-company-nysecc/

CoreCap Advisors LLC purchased a new position in shares of Chemours during the second quarter valued at approximately $64,000.

Source: https://www.etfdailynews.com/2023/03/01/healthcare-of-ontario-pension-plan-trust-fund-invests-703000-in-the-chemours-company-nysecc-2/

Earlier this month, three other companies — DuPont de Nemours Inc. and spinoffs Chemours Co. and Corteva Inc. — reached a $1.18-billion deal to resolve PFAS complaints by about 300 drinking water providers.

Source: https://www.cbc.ca/news/world/3m-pfa-forever-chemicals-lawsuit-1.6886172?cmp=rss

Lindbrook Capital LLC lifted its stake in Chemours by 117.3% in the fourth quarter.

Source: https://www.etfdailynews.com/2023/05/28/citigroup-inc-sells-30262-shares-of-the-chemours-company-nysecc/

Royal Bank of Canada lowered shares of Chemours from an “outperform” rating to a “sector perform” rating and decreased their target price for the company from $35.00 to $33.00 in a report on Tuesday, January 10th.

Source: https://www.etfdailynews.com/2023/02/02/barclays-plc-has-2-43-million-stock-holdings-in-the-chemours-company-nysecc/